BioAge Labs, Inc Cash Flow-to-Debt Ratio
BioAge Labs, Inc cash flow-to-debt ratio. BioAge Labs, Inc (BIOA) has a Cash Flow-to-Debt Ratio of -0.87x as of June 2026, meaning its operating cash flow of $-19.26 Million could theoretically repay -1% of its total liabilities ($22.02 Million) in one year. Check BIOA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioAge Labs, Inc (2013–2025)
Cash flow-to-debt ratio of BioAge Labs, Inc from 2013 to 2025. Historical debt coverage capacity for BioAge Labs, Inc across 9 annual periods. Also explore BIOA net asset momentum to track the company's year-over-year net asset growth rate.
BioAge Labs, Inc Cash Flow-to-Debt Ratio by Year (2013–2025)
BioAge Labs, Inc cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for BioAge Labs, Inc. For the full cash flow conversion analysis, see BioAge Labs, Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.57x | $-81.63 Million | $22.84 Million | ▼ -143.5% |
| 2024 | -1.47x | $-51.52 Million | $35.11 Million | ▼ -682.9% |
| 2023 | -0.19x | $-37.36 Million | $199.32 Million | ▲ +27.0% |
| 2022 | -0.26x | $-36.18 Million | $140.99 Million | ▲ +58.9% |
| 2017 | -0.63x | $-29.79 Million | $47.66 Million | ▼ -87.5% |
| 2016 | -0.33x | $-37.62 Million | $112.84 Million | ▼ -0.1% |
| 2015 | -0.33x | $-32.20 Million | $96.73 Million | ▼ -40.7% |
| 2014 | -0.24x | $-22.45 Million | $94.91 Million | ▲ +57.8% |
| 2013 | -0.56x | $-27.52 Million | $49.07 Million | — |